Pricing Log in Create free account
Friday 6 November 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024.

Revenue
+4.15%
EPS
+49.0%
Free cash flow
+49.8%
Total debt
+80.0%

Quarter to September 2026, against a year earlier

212.61 4.61 +2.22%
Market cap
$31.5B
P/E
35.6×
Fwd P/E
46.4×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Illumina, Inc. 10-K filed Feb 12, 2025

Fiscal year 2024 · Period ended Dec 29, 2024 · Filed · accepted 4:21 PM ET · Document on sec.gov · Filing index

Red flags

  • Impairment

    Illumina, Inc. recorded a goodwill impairment of $1.5 billion in fiscal 2024

    10-K filed · The filing · sec.gov

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 7, Management’s Discussion and Analysis: no comparison — the Item was not found